de Verneuil Vanina has filed 15 insider transactions across 1 company since November 2024.
Most recent transaction: a sale of 3117 shares of Vir Biotechnology, Inc. ($VIR) on February 24, 2026.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | S | Common Stock | 3117 | $9.53 | 126,682.0000 | 139,125,032 | 2.40% | 0.00% |
| Feb. 25, 2026 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | S | Common Stock | 13700 | $9.82 | 112,982.0000 | 139,125,032 | 10.81% | 0.01% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 139,125,032 | 9999.99% | 0.08% |
| Feb. 23, 2026 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | S | Common Stock | 4445 | $7.45 | 129,799.0000 | 139,125,032 | 3.31% | 0.00% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | A | Common Stock | 55000 | $0.00 | 134,244.0000 | 139,125,032 | 69.41% | 0.04% |
| Nov. 5, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP, General Counsel, Corp Sec | S | Common Stock | 2385 | $5.16 | 78,210.0000 | 139,125,032 | 2.96% | 0.00% |
| Nov. 3, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 1365 | $5.86 | 80,595.0000 | 139,125,032 | 1.67% | 0.00% |
| Feb. 26, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 7373 | $9.14 | 79,460.0000 | 137,143,286 | 8.49% | 0.01% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 137,143,286 | 9999.99% | 0.05% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | A | Common Stock | 35000 | $0.00 | 91,973.0000 | 137,143,286 | 61.43% | 0.03% |
| Feb. 24, 2025 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 5140 | $9.45 | 86,833.0000 | 137,143,286 | 5.59% | 0.00% |
| Dec. 2, 2024 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 76 | $8.22 | 56,973.0000 | 0 | 0.13% | 0.00% |
| Nov. 6, 2024 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 4397 | $10.11 | 56,973.0000 | 0 | 7.16% | 0.00% |
| Nov. 5, 2024 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 2347 | $9.47 | 61,370.0000 | 0 | 3.68% | 0.00% |
| Nov. 1, 2024 | Vir Biotechnology, Inc. | $VIR | de Verneuil Vanina | EVP and General Counsel | S | Common Stock | 1403 | $7.20 | 63,717.0000 | 0 | 2.15% | 0.00% |